- IN₹1.09tn
- IN₹994.60bn
- IN₹281.63bn
Biocon aims for revenue surge with rollout of generic weight-loss drugs
Brief: Cipla Says USFDA Inspection At Invagen Manufacturing Facility In Hauppauge, Long Island, New York, USA
India's Aurobindo Pharma posts higher profit on steady domestic demand
Brief: Cipla Says Tax Department Initiates Inspection At Cipla Facilities
Drugmaker Alembic Pharma posts earnings dip on Indian labour code changes
Factbox: Global drugmakers rush to boost US presence as tariff threat looms
Indian drugmaker Cipla falls on JPM downgrade to "neutral"
Indian drugmaker Cipla's quarterly profit falls 57% on key drug supply crunch (updated)
India's Cipla drops to lowest since May 2024 on quarterly profit miss
Indian drugmaker Cipla misses third-quarter profit view
Brief: Cipla Q3 Consol Net Profit 6.76 Billion Rupees
Preview: India's Cipla climbs; analysts upbeat on domestic earnings, cautious on US
Factbox: Global drugmakers rush to boost US presence as tariff threat looms
India's Cipla top loser on Nifty 50 after brokerages cut ratings on earnings risk
Factbox: Global drugmakers rush to boost US presence as tariff threat looms
Generic Advair nod helps India's Aurobindo Pharma, raises competition for Cipla, Citi says
Brief: Cipla Clarifies On Report USFDA Issues Form 483 Observations On Pharmathen
Focus: Lilly, Novo lock horns in India's obesity drug race
Brief: Cipla - Pfizer & Cipla Announce Exclusive Marketing, Distribution Partnership For Select Brands In India